Nicotinell Rapid Relief (Nicotine)

The nicotine in Nicotinell Rapid Relief binds to nicotinic acetylcholine receptors in the brain, partially stimulating them and prompting dopamine release. This mimics the neurochemical effects of smoking, easing withdrawal and reducing cravings while allowing the user to taper nicotine exposure over time.

The appropriate dose of Nicotinell Rapid Relief is determined by the prescribing health‑care professional based on the individual’s smoking history, level of dependence, and treatment goals. Patients should follow the prescriber’s instructions and the product’s labeling for safe use.

Safety of nicotine replacement products during pregnancy or lactation has not been definitively established. Women who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and benefits with their health‑care provider before using Nicotinell Rapid Relief.

To place an order, submit an enquiry on the Nicotinell Rapid Relief product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Nicotinell Rapid Relief delivers nicotine via the oromucosal route, offering rapid absorption and convenient dosing compared with patches or inhalers. It provides a discreet, chew‑free alternative to lozenges and may be preferred by users who experience irritation with other oral forms, while still achieving comparable cessation outcomes.

Store Nicotinell Rapid Relief below 25 °C in its original packaging, protecting it from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

The product is placed in the mouth and allowed to dissolve slowly against the oral mucosa, typically between the gum and cheek. Users should avoid chewing or swallowing the tablet whole and follow the dosing schedule prescribed by their health‑care professional.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, chest pain, rapid heart rate, high blood pressure, and swelling of the face, lips, or tongue. If any of these symptoms occur, discontinue use immediately and seek emergency medical attention.

Individuals under 18 years of age, those with known hypersensitivity to nicotine or any excipients in the product, and persons with uncontrolled cardiovascular disease should avoid using Nicotinell Rapid Relief unless advised otherwise by a qualified health‑care professional.